- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT01851382
Collection of Saliva and/ or Peripheral Blood From Healthy Volunteers for Research
Background:
- Researchers often collect samples from healthy volunteers to further their research. These samples can help better understand serious side effects and complications of transplant treatments in patients. This study will collect saliva samples from healthy volunteers.
Objectives:
- To collect saliva and blood samples from healthy volunteers for research studies.
Eligibility:
- Healthy men ages 30-70 years for Phase I of the study.
Design:
- Participants will be screened with a medical history questionnaire. They will also have a brief oral exam to check for any mouth infection.
- Participants will provide a saliva sample. The collection process will take about 5 minutes.
- No treatment will be given as part of this study.
Studie Overzicht
Toestand
Gedetailleerde beschrijving
Background:
- Chronic graft-versus-host disease (cGVHD) is a severe immunological complication that occurs after allogeneic hematopoietic stem cell transplantation (HSCT). Although oral cGVHD occurs in >25% of cGVHD patients and leads to decreased quality of life, its etiology is poorly understood.
- The primary objective of the present protocol is to enroll normal volunteers who will contribute a saliva and/or blood sample in order to compare its characteristics with those of patients with and without chronic GVHD after allogeneic HSCT. The normal control saliva and blood samples will provide a standard of comparison for patient saliva and blood samples from ongoing NCI cGVHD related protocols.
Objective:
-To collect approximately 5 ml of saliva and/or 18 cc peripheral blood from healthy volunteers as needed to support research activities.
Eligibility:
- Healthy individuals (including employees) all racial/ethnic groups, aged 18 years or older.
- Volunteers must be willing to undergo saliva and peripheral blood collection.
- No active illnesses, immunodeficiency, history of opportunistic infection, autoimmune disease, immunosuppressive medications or prior organ, bone marrow or peripheral blood stem cell transplant.
- Ability of subject to understand and provide written informed consent.
- Phase I of the study will be restricted to males, age 30-70 years
Design:
- Healthy volunteers will be offered the opportunity to participate in this protocol.
- A basic clinical dental assessment will be done.
- Saliva samples will be collected from the consenting subject.
- Peripheral blood samples may be collected from the consenting subject at the same visit.
- Protein assays will be performed on the collected saliva and blood samples.
Studietype
Inschrijving (Werkelijk)
Contacten en locaties
Studie Locaties
-
-
Maryland
-
Bethesda, Maryland, Verenigde Staten, 20892
- National Institutes of Health Clinical Center, 9000 Rockville Pike
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Beschrijving
- INCLUSION CRITERIA:
- Healthy individuals (including employees) and other healthy volunteers from all racial/ethnic groups
- Age 18 years and older, with possible restriction for age-matching to patient samples.
- Ability of subject to understand and provide written informed consent
- Subjects must participate fully and be willing to comply with the procedures of the protocol
- Phase I of the study will be restricted to males, age 30-70 years.
EXCLUSION CRITERIA:
- Active systemic illnesses, immunodeficiency, history of opportunistic infection, autoimmune disease, immunosuppressive medications
- Prior organ, bone marrow or peripheral blood stem cell transplant
- Acute dental infection
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Observatiemodellen: Case-Alleen
- Tijdsperspectieven: Prospectief
Cohorten en interventies
Groep / Cohort |
---|
Cohort 1
Healthy volunteers.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Collect saliva and peripheral blood
Tijdsspanne: End of specimen collection
|
Sample analysis for research.
|
End of specimen collection
|
Medewerkers en onderzoekers
Sponsor
Publicaties en nuttige links
Algemene publicaties
- Mays JW, Fassil H, Edwards DA, Pavletic SZ, Bassim CW. Oral chronic graft-versus-host disease: current pathogenesis, therapy, and research. Oral Dis. 2013 May;19(4):327-46. doi: 10.1111/odi.12028. Epub 2012 Oct 28.
- Bassim CW, Ambatipudi KS, Mays JW, Edwards DA, Swatkoski S, Fassil H, Baird K, Gucek M, Melvin JE, Pavletic SZ. Quantitative salivary proteomic differences in oral chronic graft-versus-host disease. J Clin Immunol. 2012 Dec;32(6):1390-9. doi: 10.1007/s10875-012-9738-4. Epub 2012 Jul 18.
Nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 130128
- 13-C-0128
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Gezonde vrijwilliger
-
University of LeicesterNational Institute for Health Research, United KingdomVoltooidPatiënten met hartfalen en behouden ejectiefractie - HFpEF | Patiënten met hartfalen met verminderde ejectiefractie - HFrEF | Healthy Controls Group - Leeftijd en geslacht afgestemd
-
University Hospital, GrenobleUniversity Hospital, Clermont-Ferrand; Grenoble Institut des NeurosciencesBeëindigdZiekte van Parkinson | Healthy Controls Group - Leeftijd en geslacht afgestemdFrankrijk